Martin Shkreli’s lifetime drug industry ban is upheldJonathan StempelJanuary 23, 2024 at 10:54 AMBy Jonathan StempelNEW YORK (Reuters) – Martin Shkreli, known for once hiking the price of a life-saving drug more than 4,000%, cannot return to the pharmaceutical industry after a federal appeals court on Tuesday upheld his lifetime ban.A three-judge panel of the 2nd U.S. Circuit Court of Appeals in Manhattan said a lower court judge acted properly in imposing the ban because of Shkreli's antitrust violations.The case had been brought by the U.S. Federal Trade Commission (FTC), joined by New York, California, Illinois, North Carolina, Ohio, Pennsylvania…